{"url_path":"/sec/cik-0001845459/8-k/2026-05-21/item-2-03","section_key":"item-2-03","section_title":"Item 2.03 Creation of a Direct Financial Obligation","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-21","source_url":"https://www.sec.gov/Archives/edgar/data/1845459/0001213900-26-060160-index.html","accession_number":"0001213900-26-060160","cik":"0001845459","ticker":null,"issuer_name":"NKGen Biotech, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1845459/0001213900-26-060160-index.html","primary_entity_key":"0001845459","primary_entity_name":"NKGen Biotech, Inc."},"word_count":34,"has_tables":true,"body_markdown":"**Item 2.03. Creation of a Direct Financial Obligation\nor an Obligation under an Off-Balance Sheet Arrangement of a Registrant.**\n\n \n\nThe disclosures set forth in Item 1.01 are incorporated\ninto this Item 2.03 by reference."}